Equity
Common Stock
Amgen Common Stock increased by 0.0% to $34.03B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1.3%, from $33.58B to $34.03B. Over 5 years (FY 2020 to FY 2025), Common Stock shows relatively stable performance with a 1.4% CAGR.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ1 2026Apr 30, 2026
How to read this metric
An increase typically signals equity financing activities such as secondary offerings or stock-based compensation issuance. A decrease may indicate share repurchases or capital restructuring.
Detailed definition
This represents the aggregate value of common stock at par value plus the additional paid-in capital received from share...
Peer comparison
This is a standard line item across all public companies, representing the primary equity funding source for operations and growth.
Metric ID:
equity_common_stocks_including_additional_paid_in_capitalHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $31.88B | $31.99B | $32.10B | $31.25B | $31.34B | $32.37B | $32.51B | $32.54B | $32.60B | $32.75B | $33.07B | $33.08B | $33.20B | $33.39B | $33.53B | $33.58B | $33.68B | $33.84B | $34.02B | $34.03B |
| QoQ Change | — | +0.4% | +0.3% | -2.6% | +0.3% | +3.3% | +0.4% | +0.1% | +0.2% | +0.5% | +1.0% | +0.0% | +0.4% | +0.6% | +0.4% | +0.1% | +0.3% | +0.5% | +0.5% | +0.0% |
| YoY Change | — | — | — | — | -1.7% | +1.2% | +1.3% | +4.1% | +4.0% | +1.2% | +1.7% | +1.7% | +1.8% | +2.0% | +1.4% | +1.5% | +1.4% | +1.3% | +1.5% | +1.3% |
Range$31.25B – $34.03B
CAGR+1.4%
Avg YoY Growth+1.6%
Median YoY Growth+1.4%
Current Streak16 quarters growth
Common Stock at Other Companies
Frequently Asked Questions
- What is Amgen's common stock?
- Amgen (AMGN) reported common stock of $34.03B in Q1 2026.
- How has Amgen's common stock changed year-over-year?
- Amgen's common stock increased by 1.3% year-over-year, from $33.58B to $34.03B.
- What is the long-term trend for Amgen's common stock?
- Over 5 years (2020 to 2025), Amgen's common stock has grown at a 1.4% compound annual growth rate (CAGR), from $31.80B to $34.02B.
- What does common stock mean?
- The total amount of money shareholders have invested in the company in exchange for common stock.